Oggi Midea ha lanciato la sua nuova campagna #H9meAzingMoments che presenta l’attaccante del Manchester City e tre volte vincitore Erling Haaland MANCHESTER, Inghilterra, 2 gennaio 2024 /PRNewswire/ — Midea oggi ha lanciato la sua nuova campagna #H9meAzingMoments che presenta l’attaccante del Manchester City e tre volte vincitore Erling Haaland. Continue Reading #H9meAzingMoments WITH ERLING HAALAND… Continue reading #H9meAzingMoments CON ERLING HAALAND – I PRODOTTI MIDEA RIVELANO LA LORO CONSONANZA CON I GOAL DI ERLING HAALAND
Category: Newswire
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
BEIJING, Jan. 1, 2024 /PRNewswire/ — The Xinhua-Yushu Wild Cordyceps Sinensis Price Index was officially released on Dec. 27th in Beijing, capital of China, indicating the accelerated development of wild cordyceps sinensis industry towards a new stage of digital, information and modern mode. Continue Reading Photo shows the launching ceremony of Xinhua-Yushu Wild Cordyceps Sinensis Price… Continue reading Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
CNOOC Limited Announces Mero2 Project Commences Production
HONG KONG, Jan. 1, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Mero2 Project has commenced production safely. Mero, Brazil’s third largest oilfield, is located in the Santos Basin pre-salt southeastern offshore Brazil. The development plan includes 4 production units, namely, Mero1, Mero2, Mero3… Continue reading CNOOC Limited Announces Mero2 Project Commences Production
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed in a Phase 3 clinical trial (GLORY-2) of higher… Continue reading Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – EH
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited (NASDAQ: EH) between January 20, 2022 and November 6, 2023, both dates inclusive (the “Class Period”), of the important February 2, 2024 lead plaintiff deadline in the securities class action… Continue reading ROSEN, TRUSTED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – EH
ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN securities during… Continue reading ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DG
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dollar General Corporation (NYSE: DG) between May 28, 2020 and August 30, 2023, both dates inclusive (the “Class Period”), of the January 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Dollar… Continue reading ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DG
CGTN: Jak Čína v roce 2024 zajistí lidem lepší život?
PEKING, 1. ledna 2024 /PRNewswire/ — Nejvyšším cílem Číny je zajistit lidem lepší život, řekl čínský prezident Si Ťin-pching během svého novoročního projevu, kterým v neděli v Pekingu zahájil rok 2024. “O naše děti by mělo být dobře postaráno a mělo by se jim dostat dobrého vzdělání. Naši mladí lidé by měli mít možnost věnovat… Continue reading CGTN: Jak Čína v roce 2024 zajistí lidem lepší život?
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: New York, N.Y., December 31, 2023. Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Roblox Corporation (NYSE: RBLX) between March 10, 2021 and February 15, 2022, both dates inclusive (the “Class Period”), of the important January 26, 2024 lead… Continue reading ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX
CGTN : Comment la modernisation chinoise ouvre de nouvelles opportunités au monde
PÉKIN, 1er janvier 2024 /PRNewswire/ — La modernisation de la Chine est une quête évolutive du peuple chinois au fil des générations. En 2023, le pays a entamé sa première année complète de mise en œuvre des principes directeurs du 20ème Congrès national du Parti communiste chinois (PCC), traçant la voie à suivre pour la… Continue reading CGTN : Comment la modernisation chinoise ouvre de nouvelles opportunités au monde